Navigenics #3 - SNP testing – can it be used for disease risk assessment?:

Navigenics #3 - “SNP testing – can it be used for disease risk assessment?

”In this third article originating from G&H’s exclusive interview with Navigenics’ Medical Director, Dr Michael Nierenberg, we explore the whole issue of SNP testing and how SNPs can be used in disease risk assessment.

Navigenics has focused on around 100 of the most definitive research papers on SNPs (single nucleotide polymorphisms) that have been most strongly associated with 18 particular diseases such as breast cancer, type II diabetes, cardiovascular disease. The company has built an algorithm (mathematical computer program) that estimates the risk of a healthy person developing a disease if their genome has the relevant SNP.”

Navigenics #3 - SNP testing – can it be used for disease risk assessment?